The company designed its Planatome technology to transform the basic scalpel with a patented nano-polishing process meant to eliminate manufacturing defects and produce a smooth surgical blade. The result, according to Entrepix, is improved post-operative outcomes including faster healing with less infections, increased wound strength and less pain with reduced nerve damage.
Phoenix-based Entrepix touts results of studies that reveal wound closure rates from a Planatome incision at over 90% just after 24 hours, claiming that the smooth surface of the Planatome blade results in less swelling and a considerable reduction in both the size and variation of scarring.
Additionally, studies showed that nerves incised with a Planatome blade showed a 25% recovery at five weeks compared to 9% recovery in nerves cut with a standard scalpel. At 12 weeks, the Planatome-incised nerves showed a 92% post-operative recovery, Entrepix said.
“Our atomically smooth surgical blades are unlike all other scalpels on the market, with inherent benefits to the patient that are innately intuitive and can be life-changing,” Entrepix Medical CEO Tim Tobin said in the release. “By employing a proven technology from the semiconductor industry, then adapting and perfecting it for use on surgical instruments, we provide surgeons an extraordinary version of their current preferred devices, dramatically transforming healing expectations through next-level performance. Research shows significant benefits when using a Planatome blade compared to a standard scalpel.”